The collaboration introduces BD Rowa™ Vmax robotic technology to deliver 24/7 prescription access, streamline pharmacy operations, and empower staff to focus on patient-centred care....
The new CLIA-waived immunoassay enables simultaneous detection of influenza A/B and SARS-CoV-2 in just 10 minutes, supporting faster, cost-effective decision-making at the point of care....
The partnership integrates Lunit’s oncology-focused AI with Agilent’s diagnostic expertise to accelerate biomarker testing, enhance drug development, and drive the next wave of precision medicine....
The Institute, led by Dr. Shyam Sathanandam, is transforming neonatal cardiac care by delivering minimally invasive PDA closures directly in the NICU—eliminating transport risks and accelerating recovery for South Florida’s most vulnerable infants....
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks...
SiBionics' next-generation devices, the GS3 Continuous Glucose Monitoring (CGM) system and the KS3 Continuous Ketone Monitoring (CKM) device, became focal points, drawing considerable attention from attendees...
With stage I diagnosis offering up to a 90 per cent cure rate, and stage II a 70 per cent 5-year survival rate...
From October 1–3, healthcare leaders will explore next-generation pharmacy, digital transformation, energy-saving solutions, and global innovations, positioning Tokyo as Asia’s hub for future healthcare trends....
The addition of Blue Spark Technologies, Inc. and QT Medical as device partners signals exciting growth for HeartcoR Solutions as a leading core lab for remote patient monitoring (RPM)...
The COHERENT-AF trial will enrol up to 360 patients across clinical sites in the United States and Europe...
